Drug Type TCR-T Cell therapy |
Synonyms NW 101, NW101 |
Target |
Action inhibitors |
Mechanism Tumor-associated antigen inhibitors(Tumor-associated antigen inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lung Cancer | Preclinical | China | 04 Apr 2023 | |
Ovarian Cancer | Preclinical | China | 04 Apr 2023 |